Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: SZMYGIN
Liczba odnalezionych rekordów: 2



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/2

Tytuł oryginału: Zakażenia dolnych dróg oddechowych.
Tytuł angielski: Lower respiratory tract infections.
Autorzy: Szmygin-Milanowska Katarzyna, Milanowski Janusz
Źródło: Med. Rodz. 2002: 5 (1) s.35-41, il., tab., bibliogr. 20 poz., sum.
Sygnatura GBL: 313,454

Hasła klasyfikacyjne GBL:
  • pulmonologia

    Typ dokumentu:
  • praca epidemiologiczna

    Wskaźnik treści:
  • ludzie

    Streszczenie angielskie: Lower respiratory tract infections (LTRI) are a heterogenous group of disorders and include: acute bronchitis, pneumonia and superinfections of chronic bronchitis. The purpose of this paper is to review and provide general guidelines for the care of patients with LTRI, which may be applicable in European countries, especially in Poland. The epidemiology, ethiology, diagnostic methods, management and treatment of LTRI are described. The aim of this article is to summarize the current state of our knowledge on LTRI and to present the European guidelines considering the aspects especially addressed to Polish general practitionairs.

    2/2

    Tytuł oryginału: Comparative study of cefaclor AF vs cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Autorzy: Haczyński Józef, Chyczewska Elżbieta, Grzelewska-Rzymowska Iwona, Małolepszy Józef, Marcinowska-Suchowierska Ewa, Milanowski Janusz, Oklek Kazimierz, Płusa Tadeusz, Słomiński Marek, Szmygin Katarzyna, Rek Mirosław
    Źródło: Med. Sci. Monitor 2002: 8 (1) s.PI1-PI7, il., tab., bibliogr. 38 poz.
    Sygnatura GBL: 313,278

    Hasła klasyfikacyjne GBL:
  • toksykologia
  • pulmonologia

    Typ dokumentu:
  • praca kliniczna
  • tytuł obcojęzyczny

    Wskaźnik treści:
  • ludzie
  • płeć męska
  • płeć żeńska
  • dorośli 45-64 r.ż.
  • dorośli = 65 r.ż.

    Streszczenie angielskie: Background: Acute exacerbations of chronic bronchitis (AECB) are the most common complication of chronic bronchitis. The majority of AECB are caused by infection. The choice of appropriate antibacterial therapy for AECB is becoming more difficult and is usually empirically, Cefaclor and cefruoxime are used for ambulatory treatment of AECB. Material/Methods: This multicenter, randomized, single blind study was undertaken in order to compare efficacy and safety of cefaclor AF (500 mg BID) and cefuroxime axetil (250 mg BID) in 10 days treatment of ambulatory patients with SECB. 170 adults were enrolled into the study. Clinical responses were assessed on 17th - 24th day after randomization. Results: Both antibiotics had high over 97 p.c. effectiveness in the treatment of AECB. There was stastically 1.7 times higher rate of patients with cough release after cefaclor treatment compared to cefuroxime (p 0.03). There was a significantly 2.25 higher rate of patients with AECB symptoms release like: increasing dyspnea, sputum volume and sputum purulence or cough in cefaclor group compard to cefuroxime (p 0.0187). Both treatment resulted in significant improvement of pulmonary peak expiratory flow (PEF). There were no differences between the rates of gastrointestinal and other side effects in both groups. Conclusions: 1. Cefaclor and cefruroxime have similar high efficacy and safety in 10 days treatment of patients with AECB. 2. Cefaclor treatment significantly higher 2.25 times reduces the rate of principle symptoms of AECB compared to cefuroxime. 3. Both antibiotics treatment significantly increase PEF, with higher tendency observed in after cefaclor treatment.

    stosując format: